The U.S. Surgeon General’s recent advisory about clinician burnout cited numerous societal, cultural, structural, and organizational causes—including excessive workloads, administrative burden, and lack of organizational support. The potential fallout of this trajectory is alarming: The advisory cites the Association of American Medical Colleges’ estimate on clinician demand outpacing supply, with an anticipated shortage of between
Read More
New Hospital-At-Home Study Focuses on Rural Health Deserts
What You Should Know: - Appalachian Regional Healthcare (ARH), based in Lexington, Ky., will use Biofourmis’ virtual care and AI-based predictive analytics technology to support a new Rural Home Hospital program delivering acute hospital-level care inside patients’ homes--including a clinical trial studying this care model in rural areas. - ARH joins Blessing Health System—which is also using Biofourmis’ solution—as one of only two U.S. participants
Read More
Biofourmis Secures $300M to Expand Virtual Care Offerings
What You Should Know: - Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round, - Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman. Transforming Patient Health Through Personalized, Predictive Care Founded in
Read More
Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services
What You Should Know: - Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services. - As part of the selection, Biofourmis is supporting the health system with its turnkey, end-to-end, home hospital solution for participation in the Rural Home Hospital project. Delivering Acute-Level Hospital Care Inside Patients’ Homes This new program allows caregivers to
Read More
Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic for Heart Failure
What You Should Know: - Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). - The Breakthrough Devices Program was created to provide patients and providers with timely access to medical devices (in this case, software as a medical device, or SaMD) by speeding up their
Read More
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More
Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care
What You Should Know: - Brigham is working with Biofourmis on a national
rollout of their co-developed technology solution, which has been refined and
scaled for use by other healthcare systems across the country seeking to
establish and execute similar home hospital programs to alleviate COVID-related
capacity issues and to receive 1:1 parity on payments from CMS. - The Hospital@HomeTM platform provides a turnkey,
end-to-end ecosystem for any health system that wants to quickly launch
Read More
Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform
What You Should Know: - Boston-based digital therapeutics leader Biofourmis
just closed a $100 million Series C funding round led by SoftBank,
bringing its total funding to $145M. - Biofourmis will be using the funding to develop, validate and commercialize several released and unreleased digital therapeutics solutions across cardiology, oncology, respiratory, and pain, with a focus on the United States and key Asian markets, including Asia Pacific, China, and
Read More
Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health
What You Should Know: - Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space. - Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. - With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More
What Health IT Thought Leaders Say HIMSS20 Would Have Focused On—If It Had Happened
What You Need to Know: Health IT thought leaders share what HIMSS20 would have focused On—if It had happened. - Hot topics include health IT to address COVID-19; artificial intelligence; EHR interoperability and usability; and more. –Kuldeep Singh Rajput, CEO of Biofourmis, Boston, Mass., which provides digital therapeutics that power personalized predictive care “Remote monitoring platforms and clinical-grade wearables combined with artificial intelligence [AI]-based
Read More
